George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.
Nothings priced in bar the lab if sold at that, no revenue or 401, never mind the biggies to come and realistic investors realise this hence 90% have and will hold until news rather than take advise from dddd man and his chums.
it all comes down to ….. no one’s getting a peep out of suzy so who do you go with…the bloke that ****ed £400k (ha, wouldn’t normally laugh but hey ho) down the swanee because he’s does not listen to anything bar his own clap trap or the bloke who’s field this is all about, ie lab, boi, elevations, deals, ho and business minded at that, or the sneaky peeping tom.
dont over think things folks, keep it simple.
Who do you listen to I wonder….
A X post from Adam this morning says it all
AstraZeneca joins KRAS push in cancer with Chinese deal. Preclinical inhibitor sold for 24M with 400M milestone package.
If only more UK small Biotechs were developing preclinical KRAS drugs like @valirxplc 😜 #VAL
Get an oncology compound in:
1. Demonstrate good bioavailability.
2. Demonstrate cell line and tumour efficacy.
2. Demonstrate early safety over a short dosing schedule.
4. Sell it to those with deep development pockets.
This is the way